Results 191 to 199 of about 35,499 (199)

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial†

Annals of Oncology, 2016
Bernardo Rapoport, S J Noga, B L Rapoport   +2 more
exaly  

Granisetron: a review of pharmacokinetics and clinical experience in chemotherapy induced - nausea and vomiting

Expert Opinion on Drug Metabolism and Toxicology, 2017
Alexandra Papaioannou
exaly  

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

Expert Opinion on Investigational Drugs, 2007

exaly  

Nausea, vomiting and cancer treatment

Ca-A Cancer Journal for Clinicians, 1978
exaly  

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Annals of Oncology, 2006
Steven M Grünberg, M S Aapro, S A Tjulandin   +2 more
exaly  

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

Expert Opinion on Drug Metabolism and Toxicology, 2009

exaly  

Self-Care Activities for the Person with Nausea and Vomiting

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Chemotherapy-Induced Nausea and Vomiting: The Importance of Acute Antiemetic Control

Oncologist, 2003
exaly  

Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

Journal of the Academy of Nutrition and Dietetics
Alex Molassiotis, Megan Crichton
exaly